Daiwa Securities Group
RANI icon

Daiwa Securities Group’s Rani Therapeutics RANI Stock Holding History

Daiwa Securities Group’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-58
Closed -$1K – 1370
2022
Q3 		$1K Hold
58
– – ﹤0.01% 1311
2022
Q2 		$1K Hold
58
– – ﹤0.01% 1318
2022
Q1 		$1K Hold
58
– – ﹤0.01% 1333
2021
Q4 		$1K Buy
+58
New +$1.32K ﹤0.01% 1353

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
ASGS
Alpha Square Group S New York $103M AUM 63.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TWA
TPB Wealth Advisors San Antonio, Texas $183M AUM 9.21% 1-Year Est. Return

Daiwa Securities Group's RANI Position: Q4 2022 in Review

Daiwa Securities Group sold out of Rani Therapeutics (RANI) in Q4 2022, closing a stake of 58 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in RANI in Q4 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 34 funds tracked by Wall St. Rank hold RANI as of Q4 2022.

  • Daiwa Securities Group reported no remaining Rani Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 58 Rani Therapeutics shares in Q4 2022, an estimated $1K.
  • Daiwa Securities Group first reported a position in Rani Therapeutics in Q4 2021 and held it in 4 quarters.
  • Daiwa Securities Group's Rani Therapeutics position peaked at $1K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held Rani Therapeutics as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.